Published in Ann Rheum Dis on May 03, 2013
High frequency ultrasound of skin involvement in systemic sclerosis - a follow-up study. Arthritis Res Ther (2015) 0.77
Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. Arthritis Res Ther (2017) 0.75
Primary Raynaud's phenomenon and nailfold videocapillaroscopy: age-related changes in capillary morphology. Clin Rheumatol (2016) 0.75
[Capillary microscopy]. Z Rheumatol (2016) 0.75
Cerberus-like is a secreted factor with neutralizing activity expressed in the anterior primitive endoderm of the mouse gastrula. Mech Dev (1997) 2.83
Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol (2000) 2.61
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis (2005) 2.48
Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT). Minerva Anestesiol (2011) 2.13
[Effects of levofolinic acid on plasma homocysteine concentrations in healthy and young women in preconceptional care]. Med Clin (Barc) (2001) 2.06
Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann Rheum Dis (2001) 1.95
Association of primary Pneumocystis carinii infection and sudden infant death syndrome. Clin Infect Dis (1999) 1.94
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis (2007) 1.90
Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study. Ann Rheum Dis (2007) 1.86
Localization of serum-derived alpha 2 macroglobulin in cultured cells and decrease after Moloney sarcoma virus transformation. Cell (1977) 1.86
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis (2002) 1.85
Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines. Rheumatology (Oxford) (2002) 1.82
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis (2010) 1.73
Heterogeneity within a large kindred with frontotemporal dementia: a novel progranulin mutation. Neurology (2007) 1.71
Cloning and characterization of a cellular apoptosis susceptibility gene, the human homologue to the yeast chromosome segregation gene CSE1. Proc Natl Acad Sci U S A (1995) 1.63
Purification and properties of filamin, and actin binding protein from chicken gizzard. J Biol Chem (1976) 1.60
Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci (1987) 1.60
Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation. Neurology (2010) 1.59
Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J Intern Med (2010) 1.54
Regulation of secondary metabolite biosynthesis: catabolite repression of phenoxazinone synthase and actinomycin formation by glucose. J Bacteriol (1972) 1.52
Articular involvement in European patients with Lyme disease. A report of 32 Italian patients. Br J Rheumatol (1990) 1.50
A modified ATP benchmark for evaluating the cleaning of some hospital environmental surfaces. J Hosp Infect (2008) 1.48
Circadian rhythms in RA. Ann Rheum Dis (2003) 1.47
The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines. Genome Res (1996) 1.46
Involvement of the hypothalamic--pituitary--adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum (2001) 1.46
The association between fibromyalgia and carpal tunnel syndrome in the general population. Ann Rheum Dis (1996) 1.40
Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis (2010) 1.38
The binding of cyclic adenosine monophosphate receptor to deoxyribonucleic acid. J Biol Chem (1972) 1.38
Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) (2004) 1.35
Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study. Ann Rheum Dis (2001) 1.33
Cyclic guanosine monophosphate and cellular growth. Science (1975) 1.29
Vitamin D and autoimmune rheumatic diseases. Rheumatology (Oxford) (2008) 1.24
Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis (2007) 1.23
Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice. Ann Rheum Dis (2010) 1.17
The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. Scand J Rheumatol (2005) 1.16
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis (2013) 1.14
Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatology (Oxford) (2006) 1.14
[Capillaroscopy and rheumatic diseases: state of the art]. Z Rheumatol (2006) 1.13
The Streptomyces peucetius dpsY and dnrX genes govern early and late steps of daunorubicin and doxorubicin biosynthesis. J Bacteriol (1998) 1.13
Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: physiopathogenetic and therapeutic perspectives. Semin Arthritis Rheum (1999) 1.11
The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis (2009) 1.09
Sex hormone status in women suffering from rheumatoid arthritis. J Rheumatol (1986) 1.08
Phosphorylation of filamin and other proteins in cultured fibroblasts. Biochem Biophys Res Commun (1977) 1.07
Structure of syringotoxin, a bioactive metabolite of Pseudomonas syringae pv. syringae. FEBS Lett (1990) 1.07
Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome. Nephrol Dial Transplant (2007) 1.07
To what extent is the new position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) 'personalised'? Diabetologia (2012) 1.05
Alcohol-drugs interaction in man: alcohol and tolbutamide. Eur J Clin Invest (1971) 1.05
Cardiovascular diseases in patients with rheumatoid arthritis: comment on the article by Koivuniemi et al. Scand J Rheumatol (2013) 1.05
Alterations of the hypothalamic-pituitary-adrenal axis in systemic immune diseases - a role for misguided energy regulation. Clin Exp Rheumatol (2011) 1.05
Nailfold capillaroscopy and classification criteria for systemic sclerosis. Clin Exp Rheumatol (2007) 1.05
Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy. Maturitas (2005) 1.03
Nailfold video-capillaroscopy in systemic sclerosis. Z Rheumatol (2004) 1.02
Multimodality imaging of intraosseous ganglia of the wrist and their differential diagnosis. Radiol Med (2012) 1.02
The purification and analysis of mechanism of action of a cyclic AMP-receptor protein from Escherichia coli. Methods Enzymol (1974) 1.02
Melatonin serum levels in rheumatoid arthritis. Ann N Y Acad Sci (2002) 1.02
Attitudes and practices of physicians and naturopaths toward herbal products, including use during pregnancy and lactation. Can J Clin Pharmacol (2000) 1.01
Regional surveillance of emergency-department visits for outpatient adverse drug events. Eur J Clin Pharmacol (2009) 1.01
Characterization of synovial fluid fibronectin from patients with rheumatic inflammatory diseases and healthy subjects. Arthritis Rheum (1984) 1.01
Role of CAS, a human homologue to the yeast chromosome segregation gene CSE1, in toxin and tumor necrosis factor mediated apoptosis. Biochemistry (1996) 1.01
Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI). Clin Exp Rheumatol (2009) 1.01
Evidence of cerebral hypoperfusion in scleroderma patients. Rheumatology (Oxford) (2000) 1.00
The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica. Rheumatology (Oxford) (2000) 1.00
Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. Ann Rheum Dis (2009) 1.00
Sonoelastography may help in the differential diagnosis between rheumatoid nodules and tophi. Clin Exp Rheumatol (2010) 0.99
An overview of rheumatological research in the European Union. Ann Rheum Dis (1998) 0.99
The Environmental Genome Project. Epidemiology (1998) 0.99
Polymyalgia rheumatica: evidence for a hypothalamic-pituitary-adrenal axis-driven disease. Clin Exp Rheumatol (2001) 0.98
Adenylate cyclase activity in fibroblasts transformed by Kirsten or Moloney sarcoma viruses. Decreased activity and loss of response to prostaglandin E1. J Biol Chem (1974) 0.98
Endoscopic diagnosis and treatment of gastric bezoars. Gastrointest Endosc (1998) 0.98
Plasma glucose concentration in symptomatic osteoarthritis: a clinical and epidemiological survey. Clin Exp Rheumatol (1990) 0.97
No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 0.97
Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. Ann Rheum Dis (2003) 0.97
Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study. Clin Exp Rheumatol (2010) 0.97
Extubation score in the operating room after liver transplantation. Acta Anaesthesiol Scand (2010) 0.96
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96
The process of aging changes the interplay of the immune, endocrine and nervous systems. Mech Ageing Dev (2001) 0.95
Implications on human fertility of the 677C-->T and 1298A-->C polymorphisms of the MTHFR gene: consequences of a possible genetic selection. Mol Hum Reprod (2002) 0.94
Monoreactive and polyreactive rheumatoid factors produced by in vitro Epstein-Barr virus-transformed peripheral blood and synovial B lymphocytes from rheumatoid arthritis patients. Scand J Immunol (1990) 0.94
A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. J Rheumatol (2001) 0.93
Sex differences in inflammation induced cartilage damage in rodents. The influence of sex steroids. J Rheumatol (1994) 0.93
Bacteriophage lambda hin function. I. Pleiotropic alteration in host physiology. J Mol Biol (1980) 0.93
Benefit of pregnancy in inflammatory arthritis. Ann Rheum Dis (2005) 0.92
Preliminary results of serum androgen level testing in men with rheumatoid arthritis. Arthritis Rheum (1984) 0.92
Neuropeptides and steroid hormones in arthritis. Curr Opin Rheumatol (1998) 0.91
Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab. Rheumatology (Oxford) (2006) 0.91
Italian validation of the Wagnild and Young Resilience Scale: a perspective to rheumatic diseases. Clin Exp Rheumatol (2010) 0.91
Impact assessment of oncology research in the European Union. Eur J Cancer (1999) 0.91
Effects of framing on teratogenic risk perception in pregnant women. Lancet (2001) 0.91
Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3. Ann Rheum Dis (2005) 0.91
Morning symptoms in rheumatoid arthritis: a defining characteristic and marker of active disease. Scand J Rheumatol Suppl (2011) 0.90
Alkane oxidation in Candida tropicalis. Biochim Biophys Acta (1973) 0.90
In etanercept-treated psoriatic arthritis patients clinical improvement correlated with an increase of serum cortisol relative to other adrenal hormones. Clin Exp Rheumatol (2008) 0.89
Stress system response and rheumatoid arthritis: a multilevel approach. Rheumatology (Oxford) (1999) 0.89
Analysis of MC4R polymorphism in Italian Large White and Italian Duroc pigs: association with carcass traits. Meat Sci (2011) 0.89